AMD Q2: Lower Data Center Growth Due To MI308 Export Restrictions

AMD received a reiterated 'buy' rating and a $196 fair value target from an analyst, driven by strong product momentum, particularly the anticipated MI350 and MI400 GPUs, which are expected to be significant near-term growth catalysts. Despite current export restrictions impacting margins, the analyst projects robust revenue growth of 30% for FY25 and 20% annually from FY26, primarily fueled by data center, Client, and Gaming segments, though potential US tariffs and TSMC reliance pose key risks.

Analysis

An analyst has reiterated a 'buy' rating for AMD, setting a $196 price target based on strong product momentum and a robust R&D pipeline. The bullish outlook is primarily driven by the anticipated launch of the MI350 and MI400 GPUs, which are expected to serve as major near-term growth catalysts fuelling revenue growth projections of 30% for FY25 and 20% annually from FY26 across data center, Client, and Gaming segments. However, this optimism is tempered by current headwinds, specifically lower data center growth and margin pressure resulting from export restrictions on the MI308. Furthermore, the analysis identifies two significant external risks: the potential imposition of new US tariffs and a critical manufacturing dependency on TSMC. The analyst, who holds a long position in the stock, views the company's innovation pipeline as a key mitigator to these challenges.

Key Decisions for Investors

• Investors aligned with the bullish thesis should treat the performance and adoption of the upcoming MI350 and MI400 GPUs as the primary catalyst for validating the analyst's aggressive 30% revenue growth forecast for FY25.
• It is critical to weigh the high-growth potential against clearly defined risks, including margin compression from existing export controls, the threat of new US tariffs, and the significant supply chain concentration risk associated with TSMC.
• Given the analyst's disclosed long position in AMD, the highly positive sentiment and specific price target of $196 should be considered with the context of potential author bias.